X4 Pharmaceuticals Inc.

NASDAQ: XFOR · Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT

X4 Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
55.7M 99.22M 121.72M 81.79M
Short-Term Investments
46.36M 15M n/a n/a
Long-Term Investments
n/a 782K 1.02M 1.32M
Other Long-Term Assets
2.08M 654K 1.23M 1.72M
Receivables
1.71M 562K 1.15M 747K
Inventory
2.82M n/a n/a n/a
Other Current Assets
5.59M 7.3M 5.81M n/a
Total Current Assets
112.17M 122.08M 128.68M 87.88M
Property-Plant & Equipment
4.84M 6.39M 8.33M 10.22M
Goodwill & Intangibles
27.35M 17.35M 17.35M 17.35M
Total Long-Term Assets
34.27M 25.18M 26.91M 29.3M
Total Assets
146.45M 147.26M 155.59M 117.18M
Account Payables
8.62M 8.95M 7.78M 4.28M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 1.1M 1.31M 795K
Other Current Liabilities
13.05M 7.1M 6.59M 5.42M
Total Current Liabilities
32.88M 22.86M 22.32M 14.02M
Long-Term Debt
75.42M 54.57M 32.3M 33.14M
Other Long-Term Liabilities
14.59M 16.11M 23.3M 826K
Total Long-Term Liabilities
91.42M 73.3M 59.21M 38.74M
Total Liabilities
124.3M 96.16M 81.53M 52.76M
Total Debt
78.09M 58.28M 38.42M 39.78M
Common Stock
171K 167K 122K 28K
Retained Earnings
-515.36M -477.9M -376.74M -282.87M
Comprehensive Income
-122K -119K -119K -119K
Shareholders Equity
22.15M 51.1M 74.05M 64.41M
Total Investments
46.36M 15M 1.02M 1.32M